Skip to main content
OpenTrials

Clinical trial condition

Stage IV Pancreatic Cancer

Explore clinical trials studying Stage IV Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

70 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IV Pancreatic Cancer trial results

Completed

Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer

NCT02050178

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer

NCT02005315

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavillion Aurora, Colorado, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA

NCT01893801

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Scottsdale Health Care Scottsdale, Arizona, United States
  • Rutgers - Cancer Institute of New Jersey (CINJ) New Brunswick, New Jersey, United States
  • Vita Medical Associates, PC Bethlehem, Pennsylvania, United States
View Trial Details
Completed

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

NCT00735917

Conditions
Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Colorado at Denver Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions